Login| Sign Up| Help| Contact|

Patent Searching and Data


Matches 1,251 - 1,300 out of 13,385

Document Document Title
WO/2005/054264A3
Compounds and methods are provided for modulating in vivo and in vivo processes mediated by selectin biniding. More specifically, selectin modulators and their use are described, wherein the selectin modulators that modulate (e.g. inhibi...  
WO/2007/028812A2
The invention relates to the CGRP antagonists of general formula (I) in which R1, R2 and R3 have the definitions given in claim 1, the tautomers, isomers, diastereomers, enantiomers, anomers, hydrates, mixtures, salts, and the hydrates o...  
WO/2007/028012A2
The present invention is directed to analogs of aminoglycoside compounds as well as their preparation and use as prophylactic or therapeutics against microbial infection.  
WO/2007/026675A1
Discloses is a process for producing α-D-glucopyranose, 3-O-decyl-2-deoxy-6-O-[2-deoxy-3-O-[(3R)-3-methoxydecyl]-6-O -methyl-2-[(11Z)-1-oxo-11-octadecenyl]amino]-4-O-phosphono- -D-glucopyranosyl]-2-[(1,3-dioxotetradecyl)amino]- or 1-(...  
WO/2007/028050A1
Compounds and methods are provided for modulating in vitro and in vivo processes mediated by selectin binding. More specifically, selectin modulators and their use are described, wherein the selectin modulators that modulate (e.g., inhib...  
WO/2006/012490A3
A novel ketogenic compound is provided having general formula (R(OCH(CH3)CH2C(O))nO)m-A wherein n is a integer between I and 10, m is an integer of 1 to 200,000, A is a monsaccharide, polysaccharide or oligosaccharide residue and R is se...  
WO/2007/023583A1
To synthesize a glycolipid derivative typified by GGPL-III, it is required to efficiently synthesize an intermediate in synthesizing the glycolipid derivative represented by the general formula (VIII). For this purpose, it is needed to c...  
WO/2007/020795A1
Gallic acid derivatives represented by the general formula (1): [wherein R1 is hydrogen, alkali metal, alkaline earth metal, transition metal, substituted or unsubstituted ammonium, or alkyl or alkenyl having 1 to 22 carbon atoms; and R2...  
WO/2006/119402A3
Compounds of the formula: (I) are described, along with pharmaceutical compositions containing these compounds, and methods of using the compounds to prevent and to treat cancer in mammals, including humans.  
WO/2007/014894A2
Glucopyranosyl-substituted ((hetero)cycloalkylethynyl-benzyl)-benzene derivatives of the general Formula (I) where the groups R1 to R6 as well as R7a, R7b, R7c are defined according to claim 1, including the tautomers, the stereoisomers ...  
WO/2007/013522A1
[PROBLEMS] To provide a process for producing a glycolipid-containing Simon potato extract or a glycosphingolipid from a Simon potato for the purpose of providing an alternative to a livestock brain ganglioside which is free from the ris...  
WO/2006/091580A3
Fuels and fuel components comprising starch are provided, as well as methods for operating a combustor such as a boiler or an internal combustion engine by feeding a starch fuel to the combustor. The starch may be a common starch or a mo...  
WO/2006/121861A3
The invention relates to a chemical genus of 4-biphenyl-1-phenylazetidin-2-ones useful in the treatment of hypercholesterolemia and other disorders. The compounds have the general formula (I). Pharmaceutical compositions and methods for ...  
WO/2007/009772A1
The present invention relates to 3-demethoxy-3-aminothiocolchicine glycosyl derivatives of general formula (I) in which R is hydrogen, methyl or hydroxymethyl. The compounds of formula (I) have myorelaxant and anti-inflammatory activity.  
WO/2006/054304A3
This invention provides for the use of a compound comprising a lipid or phospholipid moiety bond to a physiologically acceptable monomer, dimer, oligomer, or polymer, and/or a pharmaceutically acceptable salt or a pharmaceutical product ...  
WO/2007/009637A2
The invention relates to the objects which are characterised in the patent claims, that is, metal complexes which contain perfluoroalkyl having N-alkyl groups of general formula (I), to a method for the production thereof and to the use ...  
WO2005118777A8
The invention relates to a novel strain Saccharothrix actinomycete SA 103 deposited at CNCM on 16th February 2004, number I-3160 or a mutant strain thereof; a method and a medium for selection of said strain; and a method for the product...  
WO2006124720B1
Daunorubicin ("DNR") compounds synthesized with uncommon sugars exhibit enhanced effectiveness in treating various drug-resistant cancers.  
WO/2007/006152A1
A buckwheat extract comprising at least myo-inositol, D-chiro-inositol, a fagopyritol, one MAPK-stimulating compound, and one glucose-uptake inhibiting compound. A substantially pure glucose-uptake inhibiting compound selected from a buc...  
WO/2005/084307A3
This invention provides lipid or phospholipid conjugates. This invention further provides uses of the lipid or phospholipid conjugates for the preparation of medicaments for treating a subject suffering from sepsis, a dermatologic condit...  
WO/2007/003236A1
The method according to the invention comprises using as glycosyl donors high purity 2- deoxy-2-iodo derivatives of sugars of a defined configuration of C-2 carbon with O-alkyl, S- alkyl, O-aryl, S-aryl, O-heteroaryl, S-heteroaryl, O-acy...  
WO/2006/053972A3
The invention relates to silanizing agents comprising a saccharide end group and to the use thereof for the functionalization of solid supports. The invention also relates to solid supports that have been functionalized by said silanizin...  
WO/2007/004705A1
A glycolipid derivative represented by the formula (I): (I) wherein R1 represents an aldopyranaose residue, R2 represents a hydrogen atom or a hydroxyl group, A represents -CH2-,-CH(OH)-CH2- or -CH=CHCH2-, Z represents -O- or -CH2-, and ...  
WO/2004/062599A3
Compounds that are adjuvants and immunoeffectors are described and claimed. The compounds augment antibody production in immunized animals as well as stimulate cytokine production and activate macrophages. Compositions and methods for us...  
WO/2007/000967A1
A remedy for cerebral infarction which contains glycyrrhizin and/or a pharmaceutically acceptable salt thereof as the active ingredient. As the pharmaceutically acceptable salt, use may be appropriately made of glycyrrhizin ammonium salt...  
WO2006003518A3
The present invention relates to carbohydrate-phosphorylcholine conjugate molecule, and more particularly to phosphorylcholine-N-acetyl-D-galactosamine molecules and their use for treating and/or preventing a bacterial infection of the r...  
WO/2006/136429A1
The present invention relates to compounds of the formula (I); wherein R1 Js H, CH3 or OCH3; R3 = H, OH, CH3, OCH3, O-glucose or benzoyloxy; R4 = H; R5 = H or OH; R6 = H or OCH3; R7 = H, CH3, OCH3, cinnamoyloxy or (3,4,5-trimethoxy)-benz...  
WO/2006/136933A2
A composition for the treatment and/or prevention of attacks by biological agents characterised in that it comprises at least: a modulator means; a by-product of Brassicaceae seeds; water.  
WO2006105222A3
Pyrimidine having a pyridylamine group at C- 4 of the pyrimidine and an amide group on the pyridine ring (compounds of formula I) are useful in the treatment of conditions associated with excessive TGFB activity.  
WO/2006/135083A1
Disclosed are a pharmaceutical for the prevention or treatment of visceral fat syndrome and a beverage/food for the prevention or amelioration of the disease. A prophylactic or therapeutic agent for visceral fat syndrome comprising luteo...  
WO/2006/135084A1
Disclosed are a pharmaceutical for the prevention or treatment of steatohepatitis, particularly non-alcoholic steatohepatitis or fatty liver and a beverage/food for the prevention or amelioration of the disease. A prophylactic or therape...  
WO/2006/134352A1
The present invention relates to methods of preparing anthocyanins, and methods of preparing precursors of anthocyanins. The methods utilise a coupling reaction between a sugar and a suitable electrophilic precursor to form Eastern half ...  
WO/2006/133447A1
Described are novel crystalline pivaloyl furanoses and methods of crystallizing the pivaloyl furanoses. These compounds are useful as intermediates in the synthesis of compounds such as the deoxyjirimycins and nojirimycins and are partic...  
WO/2006/128738A1
The invention relates to a composition for depigmenting the skin comprising a compound of formula (I) : in which: - S represents a monosaccharide or a polysaccharide containing up to 20 sugar units; - the bond S-CH2 being a C-glycoside b...  
WO2005076743A3
The present invention is of a method and compounds for mediating a biological activity mediated by moesin, and in particular, for such a method and compounds for mediating a biological activity that is capable of being mediated through b...  
WO2006016997A3
Compounds that are adjuvants and immunoeffectors are described and claimed. The compounds augment antibody production in immunized animals as well as stimulate cytokine production and activate macrophages. Compositions and methods for us...  
WO/2006/129075A1
The present invention provides processes for the production of polysaccharides containing the L-iduronate subunit, for example, heparin-type polysaccharides. New intermediate compounds and processes developed during the production of sai...  
WO/2006/124720A1
Daunorubicin ("DNR") compounds synthesized with uncommon sugars exhibit enhanced effectiveness in treating various drug-resistant cancers.  
WO/2006/123558A1
It is intended to enable the synthesis of a saccharide derivative (for example, a polysaccharide, a glycolipid, a sugar amino acid, etc.) designed depending on the purpose at a low cost and a high yield by the phase dissolution/phase sep...  
WO/2006/124012A2
The present invention provides compositions and methods for treating and preventing Alzheimer's disease by administering to a subject an effective amount of a dammarane or ginsenoside compound. The invention also provides compositions an...  
WO/2006/120576A2
An oligosaccharide useful for a Meningitidis A vaccine contains a first mannose unit having a spacer in the alpha configuration at C-1, which spacer is capable of conjugating to a protein, and which is connected to a second mannose unit ...  
WO/2006/122296A1
Described herein are novel cerebroside compounds, designated as Turbostatin 1, Turbostatin 2, Turbostatin 3, and Turbostatin 4. These compounds were extracted and isolated from the marine mollusk Turbo stenogyrus, and their structures el...  
WO/2006/120208A1
The present invention relates to processes for preparing the compounds of general formula I, wherein the groups R1 and R3 are defined according to claim 1. Furthermore this inventions relates to intermediates obtained in these processes.  
WO2006099245A9
Methods of treating sirtuin related disorders and compounds useful in treating sirtuin related disorders are described.  
WO/2006/119402A2
Compounds of the formula: (I) are described, along with pharmaceutical compositions containing these compounds, and methods of using the compounds to prevent and to treat cancer in mammals, including humans.  
WO/2006/115312A1
The inventive molecular transporter compound shows significantly high permeability through a biological membrane such as a plasma membrane, nuclear membrane and blood-brain barrier, and accordingly, can be effectively used in delivering ...  
WO/2006/111616A1
The invention relates to the method for evaluating the potential of a chemical entity, such as an antibody, to bind to a peptide epitope derived from the divalent sialoside binding site of hemagglutinin protein of influenza virus. The in...  
WO/2006/111783A1
The present invention relates to monosaccharide derivatives as anti-inflammatory agents. The compounds disorder herein can be useful for inhibition and prevention of inflammation and associated pathologies including inflammatory and auto...  
WO2006042056A3
Methods for the targeted activation of prodrugs by enzymes, which cleave a linkage between a carbohydrate conjugate and a drug. Means to target the activation of prodrugs to specific cells by linking the enzyme to an antibody molecule. C...  
WO/2006/108903A1
A novel synthesis process for preparing sulphur/phosphorus (S/P) bidentate ligands from carbohydrates is described. The resulting novel compounds are thioglycoside derivatives with one anomerically positioned sulphur atom, meaning that t...  

Matches 1,251 - 1,300 out of 13,385